Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous 5 Days Infusion of High Dose Ifosfamide and Adriamycin in Patients With Advanced Sarcoma

NCT00002526 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00002526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous 5 Days Infusion of High Dose Ifosfamide and Adriamycin in Patients With Advanced Sarcoma
Lead sponsor
Swiss Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1993
Completion date
September 30, 1995
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, sarcoma